Sublobar Resection, Stereotactic Body Radiation Therapy, and Percutaneous Ablation Provide Comparable Outcomes for Lung Metastasis-Directed Therapy

Hunter C. Gits(Pediatric Oncology Group), Dawn Owen(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), K. Robert Shen, Matthew R. Callstrom(Mayo Clinic in Arizona), Janani Reisenauer(Mayo Clinic), Michael P. Grams(Mayo Clinic), Linh H. Vu(Mayo Clinic), William S. Harmsen(Mayo Clinic), Jamie D. Kapplinger(Mayo Clinic), Luis F. Tapias(Mayo Clinic), Christopher L. Hallemeier(Mayo Clinic in Arizona), J. John Lucido(Mayo Clinic), Steven E. Schild(Mayo Clinic Hospital), Courtney N. Day(Mayo Clinic), Stephen D. Cassivi(Mayo Clinic), Shanda H. Blackmon(The University of Texas MD Anderson Cancer Center), Dennis A. Wigle(Mayo Clinic), Brian T. Welch(Mayo Clinic), William G. Breen(Mayo Clinic in Arizona), Kenneth W. Merrell(Mayo Clinic), Yolanda I. Garces(Mayo Clinic), Jonathan B. Ashman(Mayo Clinic in Arizona), Mitra A. Khosravi Flanigan(Mayo Clinic), Kenneth R. Olivier(Mayo Clinic), Francis C. Nichols(Mayo Clinic), Patrick W. Eiken(Mayo Clinic), Sean S. Park(Mayo Clinic)
CHEST Journal
December 14, 2023
Cited by 8


Related Papers

Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
|Journal of the National Comprehensive Cancer Network|2021|1k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
|Journal of the National Comprehensive Cancer Network|2019|1k
Non–Small Cell Lung Cancer, Version 4.2024
|Journal of the National Comprehensive Cancer Network|2024|746